Abstract:2374 Pseudolarix acid B (PAB) was isolated from the traditional Chinese medical plant Pseudolarix kaempferi Gorden (Pinaceae) and originally identified as an early pregnancy-terminating agent. Angiogenesis, the formation of new blood vessels from the endothelium of the existing vasculature, is implicated in female reproductive system and embryo development. We explored the effect of PAB on angiogenesis and the underlying mechanism. Our experiments showed treatment with PAB for 72 h resulted in a dose-dependent (0.313-5μM) inhibition of Human microvessel enthothelial cell (HMEC) with an IC 50 of 0.49μM and a time-dependent proliferation inhibition manner at 5μM. PAB also exhibited the inhibition of migration and tube formation on HMEC in a dose dependent manner with IC 50 s of 0.89μM and 0.39μM respectively. In rat aorta culture PAB significantly inhibited the microvessel outgrowth. Treatment with PAB at concentration 5μM led to only a very few microvessel sprout. The anti-angiogenic effect of PAB was further confirmed by Chicken chorioallantoic membrane (CAM) assay. Cytoskeleton especially microtubule and actin filament play important roles in mitosis, cell signaling, and motility that are badly needed in the process of angiogenesis. Flow cytometry showed that PAB caused HMEC cell cycle arrest at G2/M phase. Immunocytochemical study revealed that PAB significantly disrupted both microtubule and microfilament in HMEC cells. The tubulin and actin polymerization assay in cell-free system displayed that PAB directly acts on tubulin while have no effect on actin. The actin changes as well as the subsequent cell morphology changes in PAB treated HMEC cells could be blocked by Rho kinase inhibitor, indicating the effect of PAB on cellular actin was in an indirect manner. Further investigation was focused on the manner of PAB interact with tubulin. We found PAB turned tubulin structure in a state different with that induced by known tubulin polymerization inhibitors such as colchicine and vinblastine. The tubulin structure was induced into a loose state by PAB, which was marked by the increasement of hydrophobicity and enhancement of tubulin sulfhydryls reactivity. Subsequent studies demonstrated that PAB did not bind to colchicines binding site as well as the vinblastine binding site, suggesting its binding sites on tubulin maybe a novel one. In conclusion, PAB, a natural derived compound, possesses significantly anti-angiogenic effect. PAB causes unique changes of tubulin protein by binding to a novel site on tubulin and inhibits tubulin polymerization both in vitro and in vivo, which may responsible for its anti-angiogenic effect.

PAB Possessing Anti-Angiogenic Effect Attributed by Inhibition of Tubulin Polymerization.

Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin.

Pseudolaric Acid B Inhibits Angiogenesis And Reduces Hypoxia-Inducible Factor 1 Alpha By Promoting Proteasome-Mediated Degradation

Pseudolaric Acid B Inhibits Angiogenesis and Reduces Hypoxia-Inducible Factor 1α by Promoting Proteasome-Mediated Degradation

Angiogenesis Inhibition and Cell Cycle Arrest Induced by Treatment with Pseudolarix Acid B Alone or Combined with 5-Fluorouracil

Structural Modification of an Angiogenesis Inhibitor Discovered from Traditional Chinese Medicine and a Structure-Activity Relationship Study.

Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.

Explore the Mechanism of Inhibitory Effects of Pseudolaric Acid B on MCF-7 Cells by High Content Analysis

Design, synthesis, and in vivo and in vitro biological screening of pseudolaric acid B derivatives as potential anti-tumor agents

Pseudolaric Acid B Induces Endometrial Cancer Ishikawa Cell Apoptosis and Inhibits Metastasis Through AKT-GSK-3β and ERK1/2 Signaling Pathways

In vitro antimetastatic potential of pseudolaric acid B in HSC-3 human tongue squamous carcinoma cell line

Design, synthesis, and evaluation of antitumor activity in Pseudolaric acid B Azole derivatives: Novel and potent angiogenesis inhibitor via regulation of the PI3K/AKT and MAPK mediated HIF-1/VEGF signaling pathway

Pseudolaric acid B exerts antitumor activity via suppression of the Akt signaling pathway in HeLa cervical cancer cells.

Anti-Angiogenesis Activity and the Activity of Cell Cycle Arrest of PG

Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells

Abstract 271: Diterpenoid Pseudolaric Acid B Induces M-phase Arrest and Apoptosis Primarily Through JNK Stress Signaling in LNCaP Prostate Cancer Cells

Pseudolaric Acid B Exhibits Anti-Cancer Activity on Human Hepatocellular Carcinoma Through Inhibition of Multiple Carcinogenic Signaling Pathways

Plumbagin Suppresses Endothelial Progenitor Cell-Related Angiogenesis in Vitro and in Vivo

Pseudolaric Acid B Inhibits FLT4-induced Proliferation and Migration in Non-small Cell Lung Cancer

Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma.

Antiangiogenic Activity Of Tpt In Vitro.